These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38808634)

  • 1. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents.
    Gobbo M; Joy J; Guedes H; Shazib MA; Anderson C; Abdalla-Aslan R; Peechatanan K; Lajolo C; Nasir KS; Gueiros LA; Nagarajan N; Hafezi Motlagh K; Kandwal A; Rupe C; Xu Y; Ehrenpreis ED; Tonkaboni A; Epstein JB; Bossi P; Wardill HR; Graff SL
    Expert Opin Pharmacother; 2024 Apr; 25(6):727-742. PubMed ID: 38808634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis.
    Shu Z; Li P; Yu B; Huang S; Chen Y
    Oral Oncol; 2020 Mar; 102():104559. PubMed ID: 31923856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma.
    Xia C; Jiang C; Li W; Wei J; Hong H; Li J; Feng L; Wei H; Xin H; Chen T
    Front Immunol; 2021; 12():618150. PubMed ID: 33841399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
    Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis.
    Villa A; Sonis ST
    Expert Opin Pharmacother; 2020 Apr; 21(5):541-548. PubMed ID: 31990597
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting.
    Lopes Martins AF; Nogueira TE; Morais MO; de Sousa-Neto SS; Oton-Leite AF; Valadares MC; Aires Freitas NM; Leles CR; Mendonça EF
    Support Care Cancer; 2021 Mar; 29(3):1245-1256. PubMed ID: 32621262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Jiang C; Wang H; Xia C; Dong Q; Chen E; Qiu Y; Su Y; Xie H; Zeng L; Kuang J; Ao F; Gong X; Li J; Chen T
    Cancer; 2019 Apr; 125(7):1081-1090. PubMed ID: 30521105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of polyacrylate silver salt/polyvinylpyrrolidone-based liquid oral gel in management of concurrence chemoradiotherapy-induced oral mucositis.
    Chin HL; Chung KP; Liu HC; Chen RS; Chang HH; Chen MH
    J Formos Med Assoc; 2023 Aug; 122(8):723-730. PubMed ID: 36623972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.
    Quinn B
    Eur J Cancer Care (Engl); 2013 Sep; 22(5):564-79. PubMed ID: 23731197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis.
    Nicolatou-Galitis O; Bossi P; Orlandi E; René-Jean Bensadoun
    Support Care Cancer; 2021 Oct; 29(10):5701-5709. PubMed ID: 33649918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Treatment of Oral Mucositis in Cancer Patients: A Systematic Review of Randomized Clinical Trials.
    Sant Ana G; Normando AGC; De Toledo I; Dos Reis PED; Guerra ENS
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):1851-1866. PubMed ID: 32711408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCCN Task Force Report. prevention and management of mucositis in cancer care.
    Bensinger W; Schubert M; Ang KK; Brizel D; Brown E; Eilers JG; Elting L; Mittal BB; Schattner MA; Spielberger R; Treister NS; Trotti AM
    J Natl Compr Canc Netw; 2008 Jan; 6 Suppl 1():S1-21; quiz S22-4. PubMed ID: 18289497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of photobiomodulation for prevention of oral mucositis on the quality of life of patients with head and neck cancer: a systematic review.
    Potrich AR; Só BB; Schuch LF; Wagner VP; Silveira FM; de Abreu Alves F; Prado-Ribeiro AC; Santos-Silva AR; Treister NS; Martins MD; Martins MAT
    Lasers Med Sci; 2023 Dec; 39(1):1. PubMed ID: 38057605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.
    Lee CT; Galloway TJ
    Curr Treat Options Oncol; 2022 Mar; 23(3):311-324. PubMed ID: 35244887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.